See all locations for this study
Phase 2Recruiting

Circulating Tumor DNA

Sponsored by Yale University

About this study

This is a single-arm, phase II study examining elacestrant in the adjuvant treatment of patients with ER+ breast cancer who test positive for circulating tumor DNA (ctDNA) during the screening period of the trial. Our trial will proceed in three separate phases: screening, treatment, and follow-up.

Enrolling at this location

Montefiore Einstein Comprehensive Cancer Center

The Bronx, New York

I'm interested

This study also enrolls at 6 other locations. See all.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.